Literature DB >> 30785369

May-Thurner syndrome - Are we aware enough?

Katalin Mako1, Attila Puskas2.   

Abstract

Iliac vein compression syndrome (May-Thurner syndrome - MTS) is an anatomically variable clinical condition in which the left common iliac vein is compressed between the right common iliac artery and the underlying spine. This anatomic variant results in an increased incidence of left iliac or iliofemoral vein thrombosis. It predominantly affects young women in the second or third decades of life with preponderance during pregnancy or oral contraceptive use. Although MTS is rare, its true prevalence is underestimated but it can be a life-threatening condition due to development of pulmonary embolism (PE). In this case based review the authors present three cases of MTS. All patients had been previously confirmed with PE, but despite they were admitted to hospital, diagnosed and correctly treated for PE and investigated for thrombophilia, the iliac vein compression syndrome was not suspected or investigated. With this presentation the authors would like to emphasize that MTS is mostly underdiagnosed, and it needs to be ruled out in left iliofemoral vein thrombosis in young individuals.

Entities:  

Keywords:  May-Thurner syndrome; deep vein thrombosis; iliac vein compression

Mesh:

Year:  2019        PMID: 30785369     DOI: 10.1024/0301-1526/a000775

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  2 in total

1.  Left lower limb deep venous thrombosis, May-Thurner syndrome and endovascular management.

Authors:  Khawaja B Waheed; Hassan R Mohammed; Khaled S Salem; Mohamed A Shaltout; Ali S Alshehri; Emad F Said; Abdulhadi S Almubarak; Zechariah J Arulanantham
Journal:  Saudi Med J       Date:  2022-01       Impact factor: 1.422

2.  May-Thurner Syndrome Is Aggravated by Pregnancy.

Authors:  Kuntharee Traisrisilp; Manatsawee Manopunya; Tanop Srisuwan; Wisit Chankhunaphas; Theera Tongsong
Journal:  Medicina (Kaunas)       Date:  2021-03-01       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.